Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Other hematologic neoplasm 1Myeloid 1

Conditions

Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Myelodysplastic Syndromes 1Mesothelioma, Malignant 1Leukemia 1Congenital Abnormalities 1

Interventions

Azacitidine 4Nivolumab 2sargramostim 1ruxolitinib 1rucaparib 1incomplete Freund's adjuvant 1cc-486 1bemcentinib 1abiraterone 1Tretinoin 1TTI-621 1Standard of Care 1Rituximab 1Radiotherapy 1Practice Guidelines as Topic 1Polymerase Chain Reaction 1Palliative Care 1Paclitaxel 1Methylprednisolone 1Melphalan 1Injections 1Immunoenzyme Techniques 1INCB059872 1INCB057643 1Gemcitabine 1Flow Cytometry 1Cyclosporine 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Myelodysplastic Syndromes × incomplete Freund's adjuvant × Thoracic × Clear all
NCT00398138 2016-03-02

Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
22 enrolled 7 charts
MyeloidOther hematologic neoplasmOther solid neoplasmThoracic

Congenital Abnormalities, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Leukemia, Lung Neoplasms, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡